89bio, Inc. Detailed Financials

Full historical quarterly statements

Metric2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-30
Total Revenue0021K000234K0
Cost of Goods Sold8K10K21K8K12K9K16K10K
Gross Profit-8K-10K0-8K-12K-9K-16K-10K
R&D Expenses103.9M64.4M111.3M141.4M44.9M47.4M33.6M31.4M
Operating Expenses115.8M75.9M122.0M151.9M53.4M57.3M41.2M39.3M
Operating Income-115.8M-75.9M-122.0M-151.9M-53.4M-57.3M-41.2M-39.3M
Other Income / Gains5.1M4.8M3.9M3.1M5.6M5.7M4.8M4.6M
Net Income-111.5M-71.3M-118.4M-149.1M-48.0M-51.7M-40.2M-34.7M
EPS (Diluted)-0.71-0.49-1.02-1.39-0.48-0.54-0.50-0.45
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio000000-0.0680
General And Administrative Expenses11.9M11.5M10.7M10.5M8.6M9.8M7.6M7.9M
Selling And Marketing Expenses0000-12K-9K-16K0
Selling General And Administrative Expenses11.9M11.5M10.7M10.5M8.6M9.8M7.6M7.9M
Other Expenses00-9K00000
Cost And Expenses115.8M75.9M122.0M151.9M53.4M57.3M41.2M39.3M
Interest Income6.2M6.0M5.1M5.4M6.5M6.6M5.7M5.6M
Interest Expense1.1M1.3M1.2M2.4M874K863K866K959K
Depreciation And Amortization8K-3.5M9K8K12K9K16K10K
Ebitda-109.6M-75.9M-116.9M-146.5M-47.0M-50.7M-35.5M-33.8M
Ebitdaratio00-6K000-151.650
Operating Income Ratio00-6K000-176.0940
Income Before Tax-110.8M-71.1M-118.1M-148.9M-47.8M-51.6M-36.4M-34.7M
Income Before Tax Ratio00-6K000-155.4190
Income Tax Expense753K137K257K204K134K97K3.9M0
Net Income Ratio00-6K000-171.9440
Epsdiluted-0.71-0.49-1.02-1.39-0.48-0.54-0.50-0.45
Weighted Average Shs Out157.9M116.0M116.0M107.1M99.8M95.8M80.7M76.3M
Weighted Average Shs Out Dil157.9M116.0M116.0M107.1M99.8M95.8M80.7M76.3M